S-4 filed as Factorial to merge with Cartesian III (NASDAQ: CGCT)
Filing Impact
Filing Sentiment
Form Type
425
Rhea-AI Filing Summary
Factorial Inc. and Cartesian Growth Corporation III have filed a Form S-4 registration statement in connection with their proposed business combination under a Business Combination Agreement dated December 17, 2025. The S-4 will include a preliminary and definitive proxy statement/prospectus to be distributed to Cartesian III shareholders for voting.
The companies note forward-looking statements and urge shareholders to read the proxy statement/prospectus when available; definitive materials and related documents will be mailed after the registration statement is declared effective and a record date is set.
Positive
- None.
Negative
- None.
Key Figures
S-4 filing email date: March 30, 2026
Business Combination Agreement date: December 17, 2025
Cartesian IPO prospectus date: May 5, 2025
3 metrics
S-4 filing email date
March 30, 2026
date of investor email announcing the S-4 public filing
Business Combination Agreement date
December 17, 2025
date of the agreement governing the proposed business combination
Cartesian IPO prospectus date
May 5, 2025
date of Cartesian III's final prospectus for its initial public offering referenced in the communication
Key Terms
Form S-4, proxy statement/prospectus, solicitations of proxies, forward-looking statements
4 terms
Form S-4 regulatory
"filed a registration statement on Form S-4 with the Securities and Exchange Commission"
A Form S-4 is a legal document that companies file with the government to announce and explain a major business move, such as a merger or acquisition. It provides detailed information to help investors understand how the deal might affect the company's value and future prospects, similar to a detailed blueprint that clarifies the impact of a significant change.
proxy statement/prospectus regulatory
"includes and will include a preliminary and definitive proxy statement/prospectus to be distributed"
A proxy statement or prospectus is a document that companies send to shareholders to provide important information about upcoming decisions or investments, such as voting on company issues or offering new shares to the public. It helps investors understand the details and risks involved, enabling them to make informed choices about their ownership or involvement with the company.
solicitations of proxies regulatory
"solicitations of proxies from its shareholders with respect to the proposed business combination"
forward-looking statements other
"This communication includes forward-looking statements...subject to risks, uncertainties, and other factors"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
FAQ
What did Factorial (CGCT) file with the SEC?
They filed a Form S-4 registration statement relating to a proposed business combination. The filing includes a preliminary and later definitive proxy statement/prospectus to be sent to Cartesian III shareholders for solicitation of proxies.
What is the date of the Business Combination Agreement?
The Business Combination Agreement is dated December 17, 2025. That agreement governs the proposed merger between Factorial and Cartesian Growth Corporation III as referenced in the S-4 filing communication.
Where can I obtain copies of the S-4 and proxy materials?
Free copies will be available at the SEC website www.sec.gov and by written request to Cartesian Growth Corporation III at its New York address. The filing communication specifies both sources for obtaining documents.
Who are the participants in the solicitation?
Cartesian III, Factorial, and their directors and executive officers may be participants in the proxy solicitation. Information about their interests is or will be included in the proxy statement/prospectus and prior Cartesian III filings.